ArticleCancer science2022

NLRP4 negatively regulates type I interferon response and influences the outcome in anti-programmed cell death protein (PD)-1/PD-ligand 1 therapy.

Hui Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.